Whether the pharmaceutical giant jumped or was pushed, its New York deal is a significant sign of the way the wind is blowing
Johnson & Johnson said it had already jumped. New York’s attorney general suggested the pharmaceutical giant was pushed.
Either way, the American drug maker is the first to formally agree to get out of the multibillion-dollar business of selling the powerful narcotic painkillers that drove the US opioid epidemic.
Related: Johnson & Johnson pays $230m to settle New York opioids case
Related: Big pharma executives mocked ‘pillbillies’ in emails, West Virginia opioid trial hears
Chris McGreal is the author of American Overdose, The Opioid Tragedy in Three Acts
